SCICLONE PHARMACEUTICALS has a total of 12 patent applications. Its first patent ever was published in 1992. It filed its patents most often in Poland, Australia and Canada. Its main competitors in its focus markets pharmaceuticals and biotechnology are BILLION KING INT LTD, COUR PHARMACEUTICALS DEV COMPANY INC and MERRION RES III LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Poland | 3 | |
#2 | Australia | 1 | |
#3 | Canada | 1 | |
#4 | China | 1 | |
#5 | EPO (European Patent Office) | 1 | |
#6 | Norway | 1 | |
#7 | Singapore | 1 | |
#8 | United States | 1 | |
#9 | WIPO (World Intellectual Property Organization) | 1 | |
#10 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Baxter John D | 9 |
#2 | Scharschmidt Bruce F | 9 |
#3 | Horwitz David L | 7 |
#4 | Tuthill Cynthia W | 2 |
#5 | Rudolph Alfred R | 2 |
#6 | Sinibaldi-Vallebona Paola | 1 |
#7 | Rasi Guido | 1 |
#8 | Garaci Enrico | 1 |
Publication | Filing date | Title |
---|---|---|
ZA9308110B | Treatment of hepatitis B carriers with minimal disease | |
CA2175046A1 | Method for treating hepatitis b carriers with minimal disease | |
SG64892A1 | Method for treating hepatitis b carriers with minimal disease | |
US5308833A | Method for treating hepatitis B carriers with minimal disease |